As a result of increased innovation and modernization of therapeutic treatments, the diabetes market has matured significantly during the last 20 years. Because the condition is so common, and patient numbers are likely to continue to rise in the near future, drug developers have found it to be a lucrative market. As a result, according to Global Data, a prominent data and analytics organization, the global market size, as measured by pharmaceutical sales, has expanded sixfold since 2000. The global market for diabetes monitoring devices is expected to expand at a compound annual growth rate (CAGR) of 6.5 percent from $19.7 billion in 2020 to $27.0 billion in 2025.
Title : Exercise: The panacea for overconsumption of carbohydrate.
Charles P Lambert PhD, Lambert Relentless R & D, LLC, United States
Title : Magnesium supplementation as potential means to reduce thrombotic risk in type 1 diabetes
Alan J Stewart, University of St. Andrews, United Kingdom
Title : Incorporation of dietary fibres from selected vegetation for diabesity market
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Navigating obesity, diabetes, and behavior change: A case study of a successful physician-patient partnership
Gretchen Holmes, Memorial Hospital at Gulfport, United States
Title : Diabetic retinopathy and GDM in hispanic pregnant women with toxoplasma gondii
Maureen Groer, University of Tennessee Knoxville, United States
Title : Do the STAP test --- Prevent the diabetes
Madhu S Malo, Diabetic Association of Bangladesh, United States